| Literature DB >> 23431345 |
Xiao Yu Chen1, Li Zhuang Ma, Na Chu, Min Zhou, Yiyang Hu.
Abstract
Chronic hepatitis B (CHB) is a serious public health problem, and Traditional Chinese Medicine (TCM) plays an important role in the control and treatment for CHB. In the treatment of TCM, zheng discrimination is the most important step. In this paper, an approach based on CFS-GA (Correlation based Feature Selection and Genetic Algorithm) and C5.0 boost decision tree is used for zheng classification and progression in the TCM treatment of CHB. The CFS-GA performs better than the typical method of CFS. By CFS-GA, the acquired attribute subset is classified by C5.0 boost decision tree for TCM zheng classification of CHB, and C5.0 decision tree outperforms two typical decision trees of NBTree and REPTree on CFS-GA, CFS, and nonselection in comparison. Based on the critical indicators from C5.0 decision tree, important lab indicators in zheng progression are obtained by the method of stepwise discriminant analysis for expressing TCM zhengs in CHB, and alterations of the important indicators are also analyzed in zheng progression. In conclusion, all the three decision trees perform better on CFS-GA than on CFS and nonselection, and C5.0 decision tree outperforms the two typical decision trees both on attribute selection and nonselection.Entities:
Year: 2013 PMID: 23431345 PMCID: PMC3568864 DOI: 10.1155/2013/695937
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Logic process of TCM zheng classification and progression in CHB.
Algorithm 1The description of CFS-GA algorithm.
Algorithm 2The general description of decision tree.
The selected attributes from CFS-GA algorithm.
| Selected lab indicators from CFS-GA | |||
|---|---|---|---|
| (1) TBIL | (7) IgG | (13) Alpha 1 globulin | (19) Eosinophil percentage |
| (2) TT | (8) Cr | (14) Beta globulin | (20) Hemoglobin |
| (3) HBsAg | (9) Blood glucose | (15) Gamma globulin | (21) MCV |
| (4) HBcAb-IgM | (10) TG | (16) Basophil | (22) RBC |
| (5) PH value | (11) LDL-C | (17) Basophil percentage | |
| (6) Urobilinogen | (12) Albumin | (18) Eosinophil | |
Decisive lab indicators through C5.0 boost decision tree.
| Clinical indicators of C5.0 boost decision tree induction | ||||
|---|---|---|---|---|
| (1) HBsAg | (4) PH value | (7) RBC | (10) Eosinophil | (13) TG |
| (2) LDL-C | (5) Blood glucose | (8) HBcAb-IgM | (11) Alpha 1 globulin | |
| (3) Hemoglobin | (6) Basophil | (9) Beta globulin | (12) TBIL | |
Algorithm 3Rules of C5.0 decision tree induction.
Classification results of the comparison.
| Attribute selection | Dimensions | NBTree Accu. (%) | REPTree Accu. (%) | C5.0 boost Accu. (%) |
|---|---|---|---|---|
| Non-attribute selection | 83 | 48.36 | 53.27 | 58.73 |
| CFS | 3 | 55.64 | 55.45 | 57.09 |
| CFS-GA | 22 | 55.64 | 66.18 | 73.82 |
Algorithm 4Critical lab indicators of TCM zheng progression in CHB.
The differences of the critical lab indicators in the zheng progression of CHB.
| HBsAg IU/mL | Eosinophil 109/L | LDL-C mmol/L | |
|---|---|---|---|
| A zheng | 242.96 ± 3.16 | 0.10 ± 0.01 | 3.09 ± 0.08 |
| B zheng | 229.07 ± 9.05 | 0.12 ± 0.01 | 2.80 ± 0.16 |
| C zheng | 244.48 ± 2.78* | 0.11 ± 0.01 | 2.83 ± 0.10** |
HBsAg: hepatitis B surficial antigen; LDL-C: low-density lipoprotein cholesterol. The values were expressed as mean ± S. E. M. The mean of HBsAg in C zheng had a significant difference when compared with B zheng with *P < 0.05; the mean of LDL-C in C zheng had a significant difference when compared with A zheng with **P < 0.05, and the means of Eosinophil had no significant difference between B zheng and C zheng (P > 0.05).